Pharma Now - Empowering Pharma Leadership’s Post

📣BIOCAPITAL SUMMIT PANEL PREVIEW📣 "Attracting capital to emerging biotech hubs" As we know, biotech innovation isn’t just about developing groundbreaking science; it is also about finding the capital to make it come to life. It’s an industry where scientific research and progress meet the realities of funding, regulation, and commercialization. This panel brings together venture capitalists, industry leaders, and academics to discuss strategies for attracting biotech capital to an emerging biotech hub, exploring the unique strengths and opportunities within the region to drive innovation and growth in the biotechnology sector. MODERATOR: Julia Monfrini Peev, Managing Partner - PACE Healthcare Capital ⭐ Tim Walbert, Former Chairman, President and Chief Executive Officer, Horizon Therapeutics; Sr. Advisor, Amgen ⭐ Michal Preminger, Regional Head, Johnson & Johnson Innovative Medicine, E. North America ⭐ Stephen Squinto, CIO, J.P. Morgan Life Sciences Private Capital ⭐ Dana Watt, PhD Watt, Partner, Breakout Ventures ⭐ Martin Burke, May and Ving Lee Professor for Chemical Innovation, and Professor of Chemistry, University of Illinois Urbana-Champaign #CBCSummit2024 #Biotech #Chicago #LifeSciences #Networking #Biotechnology

🌟 Advanced Therapies Week Highlight: Launch of Charles River's Global Biotech Incubator Program 🌟 Join Kerstin Dolph, Senior VP of Manufacturing at Charles River Laboratories, and host Benjamin McLeod from Convey Bio for an exciting introduction to the Charles River Incubator Program (CIP). This pioneering program supports the journey of early-stage biotechnology companies in the development of advanced therapies. The CIP is dedicated to nurturing startups by offering regulatory guidance, quality expertise, personnel training, and access to laboratory facilities, all aimed at enhancing their path to commercial success. Discover how your biotech venture can apply and benefit from this unique opportunity to accelerate growth and innovation. #AdvancedTherapiesWeek #ATW25 #AdvancedTherapies #CharlesRiver #BiotechIncubator

Live from #ATW25, Kerstin Dolph discusses the launch of Charles River’s Incubator Program, designed to help early-stage developers overcome this translation hurdle, with scientific advisory services and capabilities to bolster programs from concept to cure. Explore the benefits: https://bit.ly/40tN4qi Learn more about the program: https://bit.ly/4apDxVO

Science2Startup (S2S) has extended the deadline for applications to participate in Science2Startup. Therapeutics-focused researchers can submit proposals through the S2S website by December 2nd (by midnight ET) at https://lnkd.in/e7bPwMzX Further details regarding submissions and the review process can be found at https://lnkd.in/g6Mt5nwt S2S is an invitation-only symposium for top scientists from leading research institutions to present their startup ideas and interact with leading investors and executives in the Boston biotechnology hub.

Enveda Secures $130 Million to Deliver Multiple Clinical Readouts Colorado-based biotechnology company leveraging AI to develop new medicines from naturally available materials, Enveda Biosciences, has raised $130 million in Series C funding round spearheaded by FVP and Kinnevik. New and existing investors, including Premji Invest - US, Baillie Gifford, Lingotto Innovation, Dimension Capital, Lux Capital, True Ventures, The Nature Conservancy, Henry R. Kravis, and Cresset Partners, supported the investment round, which boosted the company’s total funding to $360 million. Read more: https://lnkd.in/gCgkNyPP Viswa Colluru, PhD #HealthcareNews #HealthcareInnovation #HealthcareTechnology #Ai #medicaldevice

Let Venture Capital Firms and NUVISAN Boost Your Drug Discovery Project! Are you working on an orphan disease drug discovery project or tackling challenging targets? This is your opportunity to collaborate with venture capitalists and scientific experts to propel your drug discovery initiative forward. The 2nd NUVISAN Innovation Challenge is seeking groundbreaking ideas in this space to accelerate the development of new treatments for patients in need. 🎯 Theme: Innovative Solutions for Orphan Diseases and Challenging Drug Targets 🎁 Prizes: Winners will have the opportunity to present their ideas to venture capitalists and receive expert scientific consultation from NUVISAN. 🌐 Who Can Apply: Companies worldwide working to address these unmet needs are encouraged to participate. 📅 Submission Deadline: October 29 Explore the event details here: https://lnkd.in/e7skKGDP We look forward to your application! #NUVISAN #ScienceCRO #InnovationChallenge #DrugDiscovery #OrphanDrugs #Biotech #VentureCapital

In the news! Find out what we had to say to Science|Business on our mission to ensure that 'Boosting Biotech & Biomanufacturing in the EU' is globally impactful for Europe. https://lnkd.in/eq_x3Jja

We are grateful for the opportunity to contribute to Conigen Bioscience, Inc. success! This partnership blends Conigen’s skill in designing bioactive proteins with North Star Scientific’s strong sales and business expertise, helping researchers drive drug discovery and translational research. We’re committed to helping startups that fuel breakthroughs and cutting-edge technologies get their solutions in the hands of as many customers possible. Read the full press release: https://lnkd.in/gkJvuPeQ #lifescience #partnerships #drugdiscovery #teamspirit #proteinscience

🔬 Uncover the Thrilling World of Biotech Innovation 🔬 The biotech industry is a high-stakes game of innovation and discovery. It's a world where the future of medicine is forged in the fires of cutting-edge research and development. The process of bringing new drugs to market is a gripping saga of scientific breakthroughs and regulatory hurdles. In this adrenaline-fueled industry, organizations strive to push the boundaries of what's possible, all while navigating the treacherous waters of regulation and medical necessity. It's a race against time and uncertainty, where the fate of groundbreaking inventions hangs in the balance. Join Bryan Jones, Phd, COO of Aardvark Therapeutics on a journey into the heart of biotech innovation, where the stakes are high, the challenges are daunting, and the rewards are nothing short of life-changing. Read the full article on our website to dive into the pulse-pounding world of biotech innovation. https://lnkd.in/e-sFrtsx #BiotechInnovation #MedicalBreakthroughs #CuttingEdgeResearch #ReadMoreAtAboveAndBeyondBiotechWebsite

Explore how biotechs can unlock early value in their commercial journey and look ahead to a brighter future at the 2024 Fierce Biotech Summit. Don’t miss our presentation in the Strategy and Dealmaking track at 2:30pm on September 30. #commercialsuccess #biotech #innovation Karla Anderson, Maya K. Desai, PhD, Michele Fuller